Factors Supporting and Hindering Adherence to Rectal Microbicide Gel Use with Receptive Anal Intercourse in a Phase 2 Trial.

about

Factors Supporting and Hindering Adherence to Rectal Microbicide Gel Use with Receptive Anal Intercourse in a Phase 2 Trial.

Item

http://www.wikidata.org/entity/Q38616485

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Factors Supporting and Hinderi ...... ntercourse in a Phase 2 Trial.

@en

type

Item

label

Factors Supporting and Hinderi ...... ntercourse in a Phase 2 Trial.

@en

prefLabel

Factors Supporting and Hinderi ...... ntercourse in a Phase 2 Trial.

@en

P1476

Factors Supporting and Hinderi ...... ntercourse in a Phase 2 Trial.

@en

P2093

Alan Sheinfil

http://www.w3.org/2001/XMLSchema#string

Albert Liu

http://www.w3.org/2001/XMLSchema#string

Alex Carballo-Diéguez

http://www.w3.org/2001/XMLSchema#string

Cheng-Shiun Leu

http://www.w3.org/2001/XMLSchema#string

Christine Tagliaferri Rael

http://www.w3.org/2001/XMLSchema#string

Ian McGowan

http://www.w3.org/2001/XMLSchema#string

Ivan C Balán

http://www.w3.org/2001/XMLSchema#string

Javier R Lama

http://www.w3.org/2001/XMLSchema#string

MTN-017 Protocol Team

http://www.w3.org/2001/XMLSchema#string

Rebecca Giguere

http://www.w3.org/2001/XMLSchema#string

P2860

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa

Facilitators of adherence to the study pill in the FEM-PrEP clinical trial

Preexposure prophylaxis for HIV infection among African women

Tenofovir-based preexposure prophylaxis for HIV infection among African women.

FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis.

Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial

Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.

Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men: Perspectives of PrEP users and high-risk PrEP naïve men.

Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations.

P2888

s10461-017-1890-7

P31

scholarly article

P356

10.1007/S10461-017-1890-7

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth Mayer

Curtis Dolezal

P577

2017-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28825142

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

P932

5818328

http://www.w3.org/2001/XMLSchema#string